Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease

Clinical trial NCT03589066 · COMPLETED

Trial details

NCT number: NCT03589066
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2018-05-15
Primary completion: 2018-10-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.